The American Journal of Psychiatry
Journal Home Search Current Issue Past Issues Subscribe All APPI Journals Help Contact Us
 
Am J Psychiatry 130:73-79, January 1973
doi: 10.1176/appi.ajp.130.1.73
© 1973 American Psychiatric Association
Quicksearch
Advanced Search
Or Search All APPI Journals
This Article
* Full Text (PDF)
* Alert me when this article is cited
* Alert me if a correction is posted
* Citation Map
Services
* Email this article to a Colleague
* Similar articles in this journal
* Similar articles in PubMed
* Alert me to new issues of the journal
* Add to My Articles & Searches
* Download to citation manager
* reprints & permissions
Citing Articles
* Citing Articles via HighWire
* Citing Articles via Google Scholar
Google Scholar
* Articles by GOODWIN, F. K.
* Articles by GORDON, E. K.
* Search for Related Content
PubMed
* PubMed Citation
* Articles by GOODWIN, F. K.
* Articles by GORDON, E. K.

Cerebrospinal Fluid Amine Metabolites in Affective Illness: The Probenecid Technique

FREDERICK K. GOODWIN M.D., ROBERT M. POST M.D., DAVID L. DUNNER M.D.1, , and EDNA K. GORDON

1 Principal Research Scientist, New York State Psychiatric Institute, New York, N.Y.

Probenecid inhibits the removal of 5-HIAA and HVA (the major metabolites of serotonin and dopamine) from the cerebrospinal fluid. The accumulation of these metabolites following high doses of probenecid was studied in patients with affective illness in order to assess central amine function. The metabolite accumulation was increased by administering the appropriate precursors (which increase amine synthesis) and was decreased by administering specific synthesis inhibitors. Compared with controls, the depressed patients had low HVA accumulation, while addicts on methadone had low 5-HIAA accumulation. Within the group of depressed patients, HVA accumulation was higher in bipolar than in unipolar patients.




This article has been cited by other articles:


Home page
Arch Gen PsychiatryHome page
B. W. Dunlop and C. B. Nemeroff
The Role of Dopamine in the Pathophysiology of Depression
Arch Gen Psychiatry, March 1, 2007; 64(3): 327 - 337.
[Full Text] [PDF]


Home page
Am. J. PsychiatryHome page
L. N. Yatham, P. F. Liddle, I-S. Shiah, R. W. Lam, E. Ngan, G. Scarrow, M. Imperial, J. Stoessl, V. Sossi, and T. J. Ruth
PET Study of [18F]6-Fluoro-L-Dopa Uptake in Neuroleptic- and Mood-Stabilizer-Naive First-Episode Nonpsychotic Mania: Effects of Treatment With Divalproex Sodium
Am J Psychiatry, May 1, 2002; 159(5): 768 - 774.
[Abstract] [Full Text] [PDF]


Home page
ScienceHome page
H. Fibiger and A. Phillips
Increased intracranial self-stimulation in rats after long-term administration of desipramine
Science, November 6, 1981; 214(4521): 683 - 685.
[Abstract] [PDF]


Home page
ScienceHome page
C. Lake, D. Sternberg, D. van Kammen, J. Ballenger, M. Ziegler, R. Post, I. Kopin, and W. Bunney
Schizophrenia: elevated cerebrospinal fluid norepinephrine
Science, January 18, 1980; 207(4428): 331 - 333.
[Abstract] [PDF]


Home page
ScienceHome page
S. Koslow and I. Butler
Biogenic amine synthesis defect in dihydropteridine reductase deficiency
Science, November 4, 1977; 198(4316): 522 - 523.
[Abstract] [PDF]


Home page
ScienceHome page
R. Post and F. Goodwin
Time-dependent effects of phenothiazines on dopamine turnover in psychiatric patients
Science, October 31, 1975; 190(4213): 488 - 489.
[Abstract] [PDF]


Home page
ScienceHome page
H. S. Akiskal and W. T. McKinney Jr.
Depressive Disorders: Toward a Unified Hypothesis: Clinical, experimental, genetic, biochemical, and neurophysiological data are integrated
Science, October 5, 1973; 182(4107): 20 - 29.
[Abstract] [PDF]


Home page
ScienceHome page
R. M. Post, F. K. Goodwin, E. Gordon, and D. M. Watkin
Amine Metabolites in Human Cerebrospinal Fluid: Effects of Cord Transection and Spinal Fluid Block
Science, March 2, 1973; 179(4076): 897 - 899.
[Abstract] [PDF]




Get information about faster international access.

Privacy Policy

Copyright © 1973 American Psychiatric Association. All rights reserved.

Home | Search | Current Issue | Past Issues | Subscribe | All APPI Journals | Help | Contact Us

American Psychiatric Publishing, Inc. American Psychiatric Association
1000 Wilson Boulevard, Suite 1825, Arlington, VA 22209-3901 * 800-368-5777 * appi at psych.org